Elutia Inc
ELUT
NASDAQ
Biotechnology
$0.94
USD
+0.08 (+9.38%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $37.54M
Volume 67.0K
Revenue
$15.97M
TTM
+1.6%
YoY
Gross Margin
54%
TTM
+16.4%
YoY
Net Income
$49.84M
TTM
+225.0%
YoY
Operating Cash Flow
$-43.76M
TTM
-51.4%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 3.0 | 6.3 | 3.3 | 3.3 | 3.1 |
YoY Growth | -55.9% | -0.4% | -9.3% | +16.2% | +5.5% |
Cost of Revenue | 1.6 | 3.2 | 1.5 | 1.4 | 1.3 |
Gross Profit | 1.4 | 3.1 | 1.9 | 1.9 | 1.8 |
Selling, General & Administrative | 4.7 | 7.5 | 5.1 | 6.2 | 5.6 |
Other Operating Expenses | 2.6 | 4.0 | 0.9 | 1.1 | 0.6 |
Total Operating Expenses | 8.2 | 12.9 | 7.1 | 8.5 | 8.2 |
Operating Income | -6.8 | -9.9 | -5.2 | -6.6 | -6.3 |
EBITDA | -3.3 | -5.0 | -3.6 | -5.2 | -5.4 |
Other Income / Expense | 5.1 | 0.8 | 5.1 | -0.3 | -1.6 |
Total Other Income / Expense | 4.9 | 0.3 | 4.8 | 0.0 | -1.5 |
Income Before Income Taxes | -1.9 | -9.6 | -0.4 | -6.5 | -7.8 |
Income Taxes | 0.0 | 0.0 | 0.0 | -0.0 | 0.1 |
Net Income | -3.9 | -9.6 | -3.9 | 70.8 | -7.5 |
Consolidated Net Income / Loss | -3.9 | -9.6 | -3.9 | 70.8 | -7.5 |
Net Income Attributable to Common Shareholders | -3.9 | -9.6 | -3.9 | 70.8 | -7.5 |
Basic EPS | -$0.10 | -$0.23 | -$0.09 | $1.65 | -$0.17 |
Diluted EPS | -$0.21 | -$0.26 | -$0.19 | $1.49 | -$0.17 |
Basic Shares Outstanding | 38.6M | 41.8M | 42.4M | 42.8M | 43.0M |
Diluted Shares Outstanding | 42.9M | 46.3M | 47.0M | 47.6M | 43.0M |